Farmacon Global and UC San Diego, organizers of the Rare Diem (virtual) Conference, August 25, are pleased to announce Dick Salvatierra, Founder and President of Americas Health Foundation will speak on access to rare disease treatments in evolving markets. Americas Health Foundation is a unique bridge between industry and governments, creating multi-stakeholder collaboration for the future of healthcare in Latin America, uniquely positioned to promote increased access to quality healthcare and treatments throughout the Americas.
Through Salvatierra’s leadership role with Americas Health Foundation, he will provide information in the areas of Federal government contracting, driving business development initiatives for planning and directing all aspects of the organizations policies, objectives and initiatives, including for Rare Disease patients, with his extensive international experience including Mexico, Ecuador and Honduras.
“Latin America is the focal-point evolving market of this conference and represents over 660 million people. It is a land of opportunity including fast enrollment to clinical trials with reduced cost and high regulatory standards where ICH guidelines are followed,” said Tylosky. “Every Rare Diem conference presenter plays a unique part in Rare Disease solutions in Latin America. Panelists also include Antoine Daher, Founder and President of Casa Hunter in Brazil, who has led in creating government policy on rare disease, positively affecting patients and families. Also, hear Harsha Rajasimha, Founder and CEO of Jeeva Informatics Solutions an eClinical cloud platform cloud platform, plus David Schlessinger, CEO Mendelics, Brazil.
“Our conference name, ‘Rare Diem’, playing off the ‘Carpe Diem’ expression, reminds us all to seize this moment in finding pathways to unravel the complexities in evolving markets and embrace solutions for Rare Disease patients which benefit us all. Be part of these important discussions,” concluded Tylosky.
REGISTER FOR THE RARE DIEM CONFERENCE HERE
For more information on Rare Diem and how to register,contact Sara Tylosky, CEO Farmacon Global or Carlos Martínez Villela 561-232-3441
